Near-misses in gambling games are losing events that come close to a win. Near-misses were previously shown to recruit reward-related brain regions including the ventral striatum, and to invigorate gambling behavior, supposedly by fostering an illusion of control. Given that pathological gamblers are particularly vulnerable to such cognitive illusions, their persistent gambling behavior might result from an amplified striatal sensitivity to near-misses. In addition, animal studies have shown that behavioral responses to near-miss-like events are sensitive to dopamine, but this dopaminergic influence has not been tested in humans. To investigate these hypotheses, we recruited 22 pathological gamblers and 22 healthy controls who played a slot machine task delivering wins, near-misses and full-misses, inside an fMRI scanner. Each participant played the task twice, once under placebo and once under a dopamine D2 receptor antagonist (sulpiride 400 mg), in a double-blind, counter-balanced design. Participants were asked about their motivation to continue gambling throughout the task. Across all participants, near-misses elicited higher motivation to continue gambling and increased striatal responses compared with full-misses. Crucially, pathological gamblers showed amplified striatal responses to near-misses compared with controls. These group differences were not observed following win outcomes. In contrast to our hypothesis, sulpiride did not induce any reliable modulation of brain responses to near-misses. Together, our results demonstrate that pathological gamblers have amplified brain responses to near-misses, which likely contribute to their persistent gambling behavior. However, there is no evidence that these responses are influenced by dopamine. These results have implications for treatment and gambling regulation.
Pathological gambling is a behavioral addiction with dramatic consequences including bankruptcy, unemployment, and relationship problems. The prevalence among college students has risen sharply in the past 10 years (Nowak and Aloe, 2014), while the rate of attempted suicide, approaching 20%, is higher than for any other addictive disorder (Bischof et al, 2015). Central to pathological gambling is the loss of control over gambling behavior and the inability to stop playing. This compulsive behavior is postulated to be fueled by cognitive distortions regarding the game structure. One example is the misappraisal of near-miss events—losing outcomes that come close to a win—which invigorate ongoing gambling behavior, conceivably by fostering an illusion of control (Clark, 2010). Although the behavioral vulnerability of pathological gamblers to such cognitive distortions is well established (Michalczuk et al, 2011), the underlying neural and neurochemical mechanisms remain elusive. We aimed to address this question using a combination of fMRI and pharmacological manipulation.
Near-miss events are a hallmark of many gambling games and are particularly frequent in slot machines, which are recognized as one of the most addictive forms of gambling (MacLaren, 2015). In healthy individuals near-misses promote extended play (Côté et al, 2003; Kassinove and Schare, 2001) and enhance gambling motivation, especially in those with strong trait illusions of control (Billieux et al, 2012). In neuroimaging studies, near-misses recruit similar brain regions to wins, despite their objective loss status. Notably, near-misses elicit stronger activity than similarly non-winning ‘full-miss’ events in the ventral striatum, a core node of the brain reward circuitry (Chase and Clark, 2010; Clark et al, 2009; Worhunsky et al, 2014). In this context, an amplified striatal response to near-misses might be a plausible neurobiological mechanism contributing to pathological gambling. However, previous fMRI studies investigating this question have led to inconsistent results. Initial studies have found increased brain responses to near-misses in problem vs non-problem gamblers (Habib and Dixon, 2010) as well as a positive correlation with symptom severity (Chase and Clark, 2010). However, other studies reported decreased striatal responses to near-misses in pathological gamblers compared with healthy controls (Worhunsky et al, 2014) as well as in healthy controls with high impulsivity, a trait that is commonly associated with pathological gambling (Shao et al, 2013).
One psychological account of near-misses postulates that these events operate by inducing inappropriate reinforcement learning signals (Clark, 2010 and Clark et al, 2013 for alternative hypotheses; but see Shao et al, 2013). Near-misses are proximal to a win, and accordingly, they may be wrongly interpreted as a sign of skill acquisition (illusion of control), thereby enhancing gambling motivation. This account is in line with observed neural signaling in the ventral striatum, which is often implicated in reinforcement learning (Delgado, 2007). One key implication of this hypothesis is that near-miss responses should be sensitive to dopamine. Dopamine has a central role in reinforcement learning, and modulates both brain and behavioral responses to learning feedback (Cools et al, 2006; Maia and Frank, 2011; Pessiglione et al, 2006). In addition, animal studies have shown that increasing dopamine transmission with amphetamine or the D2-like receptor agonist quinpirole enhances an analog of the near-miss effect in rats (Cocker et al, 2014; Winstanley et al, 2011). Our study aimed to test this hypothesis in humans.
Pathological gambling has been associated with dopaminergic dysfunction, and more specifically with a hyperdopaminergic state in the striatum. In particular, PET studies have shown enhanced amphetamine- and gambling-induced dopamine release in the striatum of individuals with pathological gambling symptoms, as compared with healthy controls (Boileau et al, 2014; Steeves et al, 2009). Dopamine D3 receptor binding in the substantia nigra was also shown to be positively correlated with gambling severity (Boileau et al, 2013). These results are in line with the observation that high dopamine states are associated with increased risk-taking in healthy humans (Oswald et al, 2015) and that dopamine D2/D3 receptor agonists increase risk-taking in both humans and animals (Morgado et al, 2014; Riba et al, 2008; St Onge and Floresco, 2009). On the basis of these results, we hypothesized that altering dopamine transmission with a dopamine D2/D3 receptor antagonist would alter striatal responses to near-misses in pathological gamblers.
To address the above questions, we set up a pharmaco-fMRI study in which pathological gamblers and healthy controls played a slot machine task that delivered wins, near-misses, and full-misses. The task was similar to that used in previous studies showing robust striatal responses to near-misses (Chase and Clark, 2010; Clark et al, 2009). We manipulated dopamine in a placebo-controlled, within-subjects manner using the selective D2/D3 receptor antagonist sulpiride. Sulpiride has previously been shown to modulate learning (Eisenegger et al, 2014; Mehta et al, 2008; van der Schaaf et al, 2014) as well as brain and behavioral responses to reward and punishment (Becker et al, 2013; Jocham et al, 2014; McCabe et al, 2011). Our primary interest was in the comparison of near-miss and full-miss events. We expected to see an enhanced striatal response to near-misses compared with full-misses in both groups, and that this response would be amplified in the pathological gamblers compared with controls. Given the contribution of prefrontal regions to gambling-related cognitive distortions (Xue et al, 2013, 2012), we further explored their influence on the striatum using functional connectivity.
MATERIALS AND METHODS
Twenty-two male pathological gamblers and twenty-two healthy controls participated in the study, following an in-depth structured psychiatric interview administered by a medical doctor (MINI Plus; Sheehan et al, 1998). All subjects provided written informed consent, which was approved by the regional research ethics committee (Commissie Mensgebonden Onderzoek, region Arnhem-Nijmegen).
Pathological gamblers were recruited through advertisement (N=18) and addiction clinics (N=4). None of the gamblers was in treatment at the time of testing, except for two of them enrolled in cognitive behavioral therapy (one for cannabis dependence—see below—and another one who was just starting a cognitive behavioral therapy for his gambling problems). Controls were recruited through advertisement. All gamblers, with the exception of one, qualified as pathological gamblers (5 DSM-IV criteria for pathological gambling). One gambler qualified as problem gambler as he met only four DSM-IV criteria. The severity of gambling symptoms was assessed using the South Oaks Gambling Screen (SOGS; Lesieur and Blume, 1987). All gamblers had a minimum SOGS score of 6 (range=6–18), whereas controls, with the exception of two subjects, had a SOGS score of 0 (range=0–2).
The two groups were matched for age, net income, body mass index, and verbal IQ (Table 1). Subjects were excluded if they consumed more than four alcoholic beverages daily; were using psychotropic medication; had a lifetime history of schizophrenia, bipolar disorder, attention deficit hyperactivity disorder, autism, eating disorder, anxiety disorder, or obsessive compulsive disorder; or had a past 6 months history of major depressive episode. Given the high co-morbidity between pathological gambling and other psychiatric disorders (Lorains et al, 2011), gamblers with the following co-morbidities were included: current cannabis dependence (N=1); past cannabis dependence (>5 months; N=1); lifetime history of dysthymia (N=1); and remitted post-traumatic stress disorder (remitted >4 years; N=2). In addition, three gamblers used cannabis weekly in the past 6 months, but did not meet the DSM-IV criteria for abuse/dependence. The control subjects did not have any history of substance abuse or dependence. A number of self-report questionnaires were further used to characterize the subjects (Table 1 and Supplementary information).
Subjects were tested once after receiving an oral dose of sulpiride (Dogmatil, 400 mg), and once after a placebo. The order of administration was randomized according to a double-blind, cross-over design (placebo-sulpiride: 10 controls, 11 gamblers; sulpiride-placebo: 12 controls, 11 gamblers). The test sessions were separated by at least 1 week. Background neuropsychological functioning, physiological measures and subjective mood were measured at several time points during the protocol (Supplementary information, Supplementary Tables S1–S3). The slot machine task (of primary interest here) was part of a larger protocol investigating the sensitivity to gains and losses within the context of a reversal learning task (Janssen et al, 2015), a mixed gamble task, and a probability discounting task. The slot machine task was performed approximately 1 h 45 min after drug intake, thus coinciding with maximal effects of sulpiride (Mehta et al, 2003).
We employed a two-reel slot machine task, similar to the one used in Clark et al (2009). The task was programmed using Neurobs Presentation (version 14.1), using sounds and 3D graphics to make the task as engaging as possible. Each trial consisted of four phases: choice, anticipation, outcome, and rating (Figure 1). In the choice phase, subjects had a maximum of 5 s to select one of six playing symbols on the left reel of the slot machine. Note that in contrast to Clark et al (2009), we did not include trials in which the playing symbol was selected by the computer, as this condition was not associated with the invigorating effect of near-misses. Following selection, the right reel spun for a variable duration anticipation phase (3.36–6.95 s) and decelerated to a standstill. In the outcome phase (3 s), if the right reel stopped on the same symbol as the one selected on the left reel, subjects won 5€ accompanied by a cash register sound. In all other cases, subjects did not win any money and heard a buzzer sound. Near-miss outcomes were defined as those where the right reel stopped one position away from the selected symbol. Full-miss outcomes were defined as those where the right reel stopped two or three positions away from the selected symbol. Finally, in the rating phase, subjects answered the question ‘How much do you want to continue to play?’ using a continuous scale ranging from ‘Not at all’ to ‘A lot’. Each trial ended with an intertrial interval of variable length (2–5 s).
The task was divided into three runs of 30 trials each. Outcomes were pseudorandomized to ensure a fair distribution of wins (1/6, 15 in total), near-misses (2/6, 15 below the payline, 15 above the payline), and full-misses (3/6, 45 in total). The sequence of outcomes was fixed to ensure a roughly equal distribution of the three types of outcomes across the three runs. This sequence was different for the 2 days, and the order was counter-balanced across drug sessions. Subjects were given oral instructions and practiced the task both before entering the scanner (12 trials) and within the scanner (8 trials). Subjects received a fixed amount of 50€ for their participation, plus a bonus corresponding to the mean earnings across the three runs, which amounted to 25€ for all subjects due to the pseudorandomized sequence of outcomes.
fMRI Data Acquisition
Imaging was conducted on a Siemens TIM Trio 3T scanner, using a 32-channel head coil. Whole brain T2*-weighted BOLD fMRI data were acquired using multi-echo echoplanar imaging (Supplementary Information).
fMRI Data Analysis
Preprocessing and statistical analyses of fMRI data were performed with SPM8. Preprocessing steps involved realignment, slice-timing correction, normalization to the MNI space and spatial smoothing (Supplementary Information).
We used the summary statistics approach for the statistical analysis, in which the data from each participant (including both drug sessions) were analyzed separately in a first-level analysis based on the general linear model (GLM), and then combined in a second-level, random effects analysis. Our first-level GLM incorporated separate regressors for the choice phase, the anticipation phase, the outcome phase, and the rating phase. The choice phase was modeled as a boxcar with a duration equal to the time between the appearance of the reel and the choice validation by the subject. The anticipation phase was modeled as a boxcar with a duration equal to the spinning time of the right reel. The three possible outcomes (win, near-miss, and full-miss) were modeled as three separate events. Finally, the rating phase was modeled as a boxcar with a duration equal to the time between the appearance of the scale and the rating validation by the subject. All these regressors were subsequently convolved with a canonical hemodynamic response function. Twelve motion parameters, including the six realignment parameters and their first derivatives, were included in our GLM. In addition, the time series of the mean signal from the white matter, cerebral spinal fluid, and out-of-brain segments were added as nuisance parameters modeling global intensity changes (Verhagen et al, 2008). Data were also high-pass filtered (128 s) to remove low-frequency signals; and an AR(1) model was applied to adjust for serial correlations in the data.
At the second level, we first examined the contrast (near-miss>full-miss) across drug sessions. This was done within each group separately and between groups. Then, we examined the main effect of drug on the contrast (near-miss>full-miss) across groups, as well as within each group separately. Finally, we examined the interaction of drug and group on the contrast (near-miss>full-miss). Comparisons within and across groups were performed using one-sample t-tests; and comparisons between groups were performed using two-sample t-tests. We used the same procedure to examine the response to wins compared with non-wins, using the contrast (win>near-miss and full-miss). Results were thresholded with a voxel-wise p<0.05 family-wise error (FWE) corrected for multiple comparisons across the whole-brain (pFWE whole-brain<0.05). On the basis of our a priori hypothesis about the role of the ventral striatum in pathological gambling as well as near-misses, we further applied this correction to a small volume corresponding to this region (pFWE small volume<0.05). This volume was defined as the union of two 10-mm spheres centered around the striatal peak voxels reported in a previous study for the same contrast of near-misses vs full-misses (Clark et al, 2009).
To illustrate our whole-brain results, we extracted the percent signal change from several functional clusters using the rfxplot toolbox (Gläscher, 2009). To investigate potential changes of fronto-striatal coupling as a function of outcome and group, we examined functional connectivity using a generalized PsychoPhysiological Interaction (gPPI, Supplementary Information).
Motivation ratings were first analyzed using a four-way ANOVA with Outcome (win/near-miss/full-miss) and Drug (sulpiride/placebo) as within-subject factors, and Group (controls/gamblers) and Drug Order (placebo-sulpiride/sulpiride-placebo) as between-subject factors (Figure 2). The motivation to continue gambling was higher in the pathological gamblers than in the healthy controls, as indicated by a main effect of Group (F(1,40)=7.58, p=0.009). Motivation was also modulated by the type of preceding outcome, as indicated by a strong main effect of Outcome (F(2,80)=27.25, p<0.001). As expected, wins elicited higher motivation than near-misses and full-misses (F(1,40)=28.57, p<0.001), and in line with previous studies (Clark et al, 2009, 2013), near-misses elicited higher motivation than full-misses (F(1,40)=4.83, p=0.034). The effect of Outcome on motivation did not differ between groups, as revealed by a non-significant Group × Outcome interaction (p=0.76). There was no main effect of Drug or any Drug × Group or Drug × Outcome interactions (all p>0.19). Drug Order did not interact with the Drug factor (p=0.29), suggesting no reliable session effects.
We further investigated changes in motivation ratings over time, using a four-way ANOVA with Outcome, Drug, and Run (1/2/3) as within-subject factors, and Group as a between-subject factor. The main effect of Run was significant (F(2,84)=12.43, p<0.001), reflecting a decline of motivation to continue gambling over time. However, there were no significant Run × Group or Run × Outcome × Group interactions (all p>0.37), suggesting that this decline was not significantly different between groups nor did it vary differently between groups as a function of outcome.
In the pathological gamblers, higher levels of distortions (reflected by lower GBQ scores) predicted higher motivational ratings after all three outcomes (all r−0.44, p<0.05). These correlations were not present in controls (all p>0.29).
All analyses referred to in this section can be accessed at http://neurovault.org/collections/1186/. Replicating previous results (Clark et al, 2009), we found that across drug sessions near-misses elicited stronger BOLD signal than full-misses in the bilateral ventral striatum, in both controls (x,y,z=−10, 8, 0, T=9.40; 10, 13, 0, T=8.00, pFWE whole-brain<0.005) and pathological gamblers (x,y,z=−10, 10, 0, T=13.61; 12, 10, 2, T=13.33, pFWE whole-brain<0.001) (Figure 3a). Similar results were observed in the bilateral anterior insula (Supplementary Tables S4 and S5). In line with our hypothesis, striatal responses to near-misses (compared with full-misses) were stronger in pathological gamblers than in controls (x,y,z=−10, 10, 0, T=3.88; 12, 10, 2, T=3.97, pFWE small volume<0.05) (Figure 3b). Whole-brain analyses did not reveal any other significant group differences (Supplementary Tables S6 and S7). Extraction of percent signal in the ventral striatum change further revealed that this Outcome × Group interaction was driven by an amplified response to near-misses in pathological gamblers compared with controls, while the response to full-misses was comparable across groups. Additional sensitivity analyses showed that the above group difference was unlikely to be driven by potentially confounding variables such as smoking, anxiety, or depression (Supplementary Information). We also examined whether brain responses to near-misses were modulated by GBQ scores or motivation ratings across participants in each group. These analyses did not reveal any significant correlations, either at the whole-brain level or in small striatal and insular regions of interest derived from the above analyses.
We then tested whether the enhanced striatal response in gamblers extended to win outcomes, using the contrast between wins and all non-win outcomes (ie, near-misses and full-misses). As expected, this contrast revealed strong signal change in each group throughout the reward system, particularly in the ventral striatum (Supplementary Figure S1A, Supplementary Tables S8 and S9). However, there were no significant differences between controls and gamblers, either at the whole-brain level or within our striatal volume of interest (Supplementary Figure S1B,Supplementary Tables S10 and S11).
We further investigated whether the enhanced striatal response to near-misses in gamblers was accompanied by a differential fronto-striatal connectivity, given the role of prefrontal regions in cognitive distortions. Using the striatal voxels from the group difference map as a seed, we examined gPPI connectivity with the rest of the brain as a function of Outcome (near-misses vs full-misses) and Group. There were no supra-threshold effects according to our stringent whole-brain voxel-wise statistical thresholding procedure, although for completeness we describe in the Supplementary Information an interesting gPPI in the left lateral prefrontal cortex at a whole-brain cluster-level corrected threshold (Supplementary Figure S2).
Finally, we investigated the effect of our pharmacological manipulation on the brain responses to near-misses compared with full-misses. We did not observe any drug effects across groups, either at the whole brain level or within our striatal volume of interest. Similarly, we did not observe any drug effects in either group examined separately (Supplementary Figure S3). This absence of drug effect was further illustrated by the extraction of percent signal change in the striatum, which showed a very similar pattern of activation in the sulpiride and placebo conditions (Figure 4). The striatal responses to near-misses were actually strongly correlated between drug sessions across all participants (r=0.51, p<0.001), suggesting that it represents a relatively stable trait. Finally, direct group comparisons did not reveal any differential effect of sulpiride between gamblers and controls, either at the whole brain level or within our striatal volume of interest. We also checked the sulpiride effect on the contrast between win and non-win outcomes, and similarly did not observe any reliable modulation of win-related activity.
The present study demonstrates that ventral striatal responses to near-misses are amplified in pathological gamblers compared with healthy controls. Such a group difference was not present following win outcomes. In addition, contrary to our hypothesis, we did not observe any modulation of brain responses to near-misses by sulpiride.
Our results advance earlier findings that showed qualitatively enhanced responses to near-misses in the midbrain of problem gamblers (Chase and Clark, 2010; Habib and Dixon, 2010). The present study extends these previous observations to the striatum and establishes, for the first time, a quantitative difference in near-miss responses between clinically characterized pathological gamblers and healthy controls. The recruitment of the reward system by near-misses is postulated as a mechanism that underlies the invigorating effect of these events on gambling behavior (Clark et al, 2009). Several hypotheses have been formulated regarding the underlying psychological mechanism. The most popular hypothesis builds on the prominent role of the ventral striatum in reinforcement learning, and posits that enhanced activity in the striatum would reflect aberrant learning about skill acquisition (Billieux et al, 2012). Given that such skills are irrelevant in a context where outcomes depend purely on chance, this aberrant learning contributes to an illusion of control. This idea is consistent with the fact that pathological gamblers are known to maintain strong gambling-related cognitive distortions, as illustrated, eg, by low scores on the Gambling Beliefs Questionnaire in our study (Table 1). It is further in line with the negative correlation observed between these scores and the motivation to continue gambling following near-misses in pathological gamblers (although this correlation was also observed following wins and full-misses).
An alternative account of near-misses suggests a link with the aversive emotional states triggered by missing the jackpot, such as frustration (Dixon et al, 2011). In line with this idea, near-misses are often rated as less pleasant than full-misses and elicit larger skin conductance responses (Clark et al, 2009; Dixon et al, 2013; Stange et al, 2015). Accordingly, it is possible that the enhanced striatal response to near-misses seen here reflects enhanced negative arousal and frustration (see eg, Shao et al, 2013).
Finally, some authors have suggested that near-misses boost gambling motivation in part by generating ‘upward’ counter-factual thoughts, where players mentally simulate the missed win (Clark et al, 2013; Wu et al, 2015). This hypothesis predicts different reactions to near-misses before vs after the payline, as counter-factual thoughts differ in these two situations. In line with this idea, Clark et al (2013) have shown that near-misses before the payline are more motivating while near-miss after the payline is more unpleasant and lead to higher skin conductance responses. However, supplementary analyses (not shown here) did not reveal any differences between near-misses before and after the payline, and our results are thus unable to support this counter-factual account.
Our results also revealed robust responses to near-misses in the bilateral anterior insula, consistent with previous reports (Chase and Clark, 2010; Clark et al, 2009). In particular, a lesion study in humans showed that insula damage abolishes the boost in motivation induced by near-misses (Clark et al, 2014). Given the role of the insula in interoception, it has been hypothesized that the effect of near-misses might be partly mediated by an abnormal representation of gambling-related bodily states. Although our results are not in contradiction with this hypothesis, the absence of group difference in the insula (even at a very liberal threshold of p<0.05 uncorrected) suggests that the enhanced gambling-related cognitive distortions observed in pathological gamblers might not be subserved by abnormal processing of bodily states, but rather by inappropriate reinforcement learning as previously suggested.
As expected, motivation ratings to continue gambling were higher following near-misses than full-misses, and were overall higher in pathological gamblers than in controls. However, there was no group-by-outcome interaction, and thus no evidence of an enhanced invigorating effect of near-misses in gamblers compared with controls. We suspect that this might be due to the limited sensitivity of our subjective rating procedure for measuring gambling motivation: the repetition of ratings on every trial, combined with the lack of behavioral relevance of these ratings for the participants, might have made the rating procedure boring and thus less reliable for some participants. In the future, more sensitive measures of gambling motivation such as persistent play (Billieux et al, 2012; Clark et al, 2013) or perhaps salivation (Wadhwa and Kim, 2015) might be used to reveal the boosting effect of near-misses on motivation in pathological gamblers.
Interestingly, our results did not reveal any group differences in reward-related brain regions following win outcomes. This negative result is unlikely to reflect a lack of statistical power, given that we observed a clear group difference in the contrast between near-misses and full-misses. This observation bears relevance in the context of the recent debate questioning whether or not pathological gamblers have a hypo-active reward system (Leyton and Vezina, 2012). Whereas some studies have reported blunted brain responses to monetary rewards in pathological gamblers (Balodis et al, 2012; de Ruiter et al, 2009; Reuter et al, 2005), others have reported normal to exaggerated responses (Hewig et al, 2010; Oberg et al, 2011; Sescousse et al, 2013). Importantly, we employed an ecologically valid slot machine task with relatively high amounts of money that were delivered for real, raising confidence that our observations do not reflect a lack of behavioral relevance as has been suggested for previous studies (Leyton and Vezina, 2012, 2013). In such a realistic context, our findings thus suggest that the sensitivity of pathological gamblers to gains might not be compromised, but that instead their sensitivity to certain losing events, ie, near-misses, might be distorted.
Finally, in contrast to our hypothesis, sulpiride did not induce any detectable modulation of behavioral or brain responses to near-misses. This is consistent with a previous report showing no effect of haloperidol on near-miss responses in recreational gamblers, although in that study it was unclear whether haloperidol was functionally active (Porchet et al, 2013). In the present case, the negative results are unlikely to result from a lack of central action of sulpiride, since our drug manipulation showed clear effects in several other tasks within the same protocol (see eg, Janssen et al, 2015). One possibility is that sulpiride might produce a variable effect across participants, as a result of inter-individual differences in endogenous dopamine. Indeed, previous studies have shown that the effect of dopamine agents varies considerably, and can even go in opposite directions, depending on baseline levels of dopamine synthesis as measured with neurochemical PET (Cools and D’Esposito, 2011; Cools et al, 2009). Such variations could have been amplified by the use of a relatively low dose of sulpiride, which may act pre-synaptically to increase dopamine transmission in some individuals (Frank and O’Reilly, 2006). In the present study, it is therefore conceivable that the striatal response to near-misses was enhanced by sulpiride in some participants, but decreased in others, therefore nullifying any group effect. Note however that impulsiveness and working memory, as putative proxy measures of baseline dopamine levels, did not predict drug effects on near-miss responses (Supplementary Information). Alternatively, striatal responses to near-misses might not depend on the signaling from dopamine D2/D3 receptors, for which sulpiride has high affinity, but rather on D4 receptors for which sulpiride is 10-fold less selective (Vallone et al, 2000). Supporting this idea, a recent study in rats has shown that selective D4 receptor agents were effective in modulating an analog of the near-miss effect, while selective D2/D3 receptors agents had no effect (Cocker et al, 2014).
One should also emphasize that the role of dopamine in pathological gambling has been hotly debated in recent years, due to the accumulation of inconsistent and null findings (Linnet, 2013; Potenza, 2013). For instance, pharmacological studies have shown that dopamine-enhancing and dopamine-blocking agents have intriguingly similar effects on gambling behavior in pathological gamblers (Zack and Poulos, 2004, 2007). Furthermore, raclopride PET studies have failed to demonstrate, as is the case in substance addiction, that striatal dopamine D2 receptor density is altered in pathological gambling (Boileau et al, 2013; Clark et al, 2012). The complex and incomplete picture which is emerging suggests that other neurotransmitters are likely involved in gambling addiction. One interesting possibility in the case of near-misses is that they may operate through the noradrenergic system, via its role in computing ‘risk prediction errors’ (Preuschoff et al, 2011). Near-misses induce an upward re-evaluation of the winning probability, and thus elicit such risk prediction errors. Interestingly, pathological gamblers have been seen to display an under-active noradrenergic system (Pallanti et al, 2010), which could be driven by chronic activation in response to near-miss events.
In short, our study reveals amplified striatal responses to near-miss events in pathological gamblers. This finding fits nicely with the idea that near-misses hijack the reward system and generate aberrant learning about skill acquisition, eventually leading to persistent and detrimental gambling behavior. These findings have implications in terms of prevention and treatment, such as further limiting the frequency of near-misses in gambling games (Harrigan, 2008), and incorporating more systematic demystification of illusion of control in cognitive behavioral therapy.
FUNDING AND DISCLOSURE
RC has been a consultant for Pfizer and Abbvie, but she is not an employee or a stock shareholder of either of these companies. LC is the Director of the Centre for Gambling Research at UBC, which is supported by the Province of British Columbia government and the British Columbia Lottery Corporation. LC has also consulted for Cambridge Cognition Ltd and has received a speaker honorarium from Svenska Spel (Sweden).
GS was supported by a Veni grant from the Netherlands Research Organization (NWO).
About this article
Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)
Molecular Psychiatry (2018)